Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Hu Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7274-287X; OpenAlex author ID A5077970092. Sources: OpenAlex.

Their work

Papers
12 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2020: 5 papers · 2021: 3 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 12

  1. An interpretable machine learning model for predicting survival in pancreatic cancer via SHAP: a multicenter study. Co-author DOI 10.1007/s00535-026-02348-x↗
  2. PD-L1 levels, TP53 mutation profiles, and survival outcomes in pancreatic cancer differ by immune-nutritional status. First author DOI 10.1186/s12957-025-03818-x↗
  3. Prognostic significance of advanced lung cancer inflammation index in resectable pancreatic cancer: A retrospective study. First author DOI 10.4240/wjgs.v17.i9.108551↗
  4. Overexpression of ZNF488 supports pancreatic cancer cell proliferation and tumorigenesis through inhibition of ferroptosis via regulating SCD1-mediated unsatur… Co-author DOI 10.1186/s13062-023-00421-6↗
  5. Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2021.04.007↗
  6. Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocarcinoma Patients Undergoing Radical Pancr… Co-author DOI 10.12659/msm.931868↗
  7. Combination of preoperative fibrinogen and D-dimer as a prognostic indicator in pancreatic ductal adenocarcinoma patients undergoing R0 resection. First author DOI 10.4240/wjgs.v13.i3.279↗
  8. Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System. Co-author DOI 10.1155/2020/9093729↗
  9. Over-expression of ANP32E is associated with poor prognosis of pancreatic cancer and promotes cell proliferation and migration through regulating β-catenin. Co-author DOI 10.1186/s12885-020-07556-z↗
  10. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection. First author DOI 10.3748/wjg.v26.i46.7382↗
  11. [The relationship between the index of lymph node metastasis and the prognosis of pancreatic cancer patients after R0 resection]. Co-author DOI 10.3760/cma.j.cn112152-20191125-00760↗
  12. Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma. Co-author DOI 10.3892/ol.2020.11495↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chengfeng Wang · 5 shared papers, 2020–2021 · strength 0.71
  2. Yongxing Du · 4 shared papers, 2020–2021 · strength 0.58
  3. Dongbing Zhao · 2 shared papers, 2025–2026 · strength 0.56
  4. Lipeng Zhang · 4 shared papers, 2020–2021 · strength 0.56
  5. Guotong Qiu · 4 shared papers, 2020–2021 · strength 0.50
  6. Jianwei Zhang · 3 shared papers, 2020–2023 · strength 0.39
  7. Zongting Gu · 3 shared papers, 2020–2021 · strength 0.37
  8. Chaorui Wu · 2 shared papers, 2020 · strength 0.30
  9. Heyun Zhang · 1 shared paper, 2026 · strength 0.29
  10. Zheng Li · 1 shared paper, 2026 · strength 0.29
  11. Chengfeng Wang · 2 shared papers, 2020–2023 · strength 0.28
  12. Ze‐Lin Wen · 1 shared paper, 2025 · strength 0.27
  13. Zheng Li · 1 shared paper, 2025 · strength 0.25
  14. Dongbing Zhao · 1 shared paper, 2025 · strength 0.25
  15. C F Wang · 1 shared paper, 2020 · strength 0.24
  16. Shuisheng Zhang · 1 shared paper, 2023 · strength 0.17
  17. Qifeng Xiao · 1 shared paper, 2023 · strength 0.17
  18. Shunda Wang · 1 shared paper, 2023 · strength 0.17
  19. Dan Li · 1 shared paper, 2023 · strength 0.17
  20. Cheng‐Feng Wang · 1 shared paper, 2020 · strength 0.16
  21. Xiaohao Zheng · 1 shared paper, 2021 · strength 0.16
  22. Lipeng Zhang · 1 shared paper, 2021 · strength 0.16
  23. Ke Xu · 1 shared paper, 2021 · strength 0.11
  24. Guang Li · 1 shared paper, 2021 · strength 0.11
  25. Jin Peng He · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.